These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10674374)

  • 1. Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone.
    Shapiro J; Sundberg JP; Bissonnette R; McElwee KJ; McLean DI; Carroll JM; Oliver RF; Tang L; Lui H
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):239. PubMed ID: 10674374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata.
    Tang L; Lui H; Sundberg JP; Bissonnette R; McLean DI; Shapiro J
    J Am Acad Dermatol; 2003 Dec; 49(6):1013-9. PubMed ID: 14639378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of alopecia areata with diphencyprone].
    Suditu G; Toma A; Voiculescu M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.
    Happle R; Klein HM; Macher E
    Arch Dermatol Res; 1986; 278(3):214-8. PubMed ID: 2873796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks].
    Lutz G; Kreysel HW
    Z Hautkr; 1989 Oct; 64(10):898-900. PubMed ID: 2588751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of alopecia areata with diphencyprone.
    Hatzis J; Georgiotouo K; Kostakis P; Anastasiadis G; Tosca A; Varelzidis A; Straigos J
    Australas J Dermatol; 1988 Apr; 29(1):33-6. PubMed ID: 2977943
    [No Abstract]   [Full Text] [Related]  

  • 9. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
    Freyschmidt-Paul P; Happle R; Hoffman R
    J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance.
    Weise K; Kretzschmar L; John SM; Hamm H
    Dermatology; 1996; 192(2):129-33. PubMed ID: 8829494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of alopecia areata with diphenylcyclopropenone].
    Ochsendorf FR; Mitrou G; Milbradt R
    Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.
    Sun J; Silva KA; McElwee KJ; King LE; Sundberg JP
    Exp Dermatol; 2008 Oct; 17(10):793-805. PubMed ID: 18798913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Onset of the effect in treatment of alopecia areata with diphenylcyclopropenone].
    Perret CM
    Hautarzt; 1989 May; 40(5):319. PubMed ID: 2500410
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
    Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
    Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
    J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.